​

Funding Round

Series A - Antios Therapeutics

Series A - Antios Therapeutics

Investment Firm

Overview

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Announced Date

Nov 27, 2018

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Domain Associates

Domain Associates

Domain Associates is a early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

6

Investor Name
Participant InvestorDelos Capital
Participant InvestorGeorgia Research Alliance
Participant InvestorCAM Capital
Participant InvestorDomain Associates
Participant InvestorFonds de solidarité FTQ

Round Details and Background

Antios Therapeutics raised $25000000 on 2018-11-27 in Series A

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 27, 2018
Series A - Antios Therapeutics
7-25.0M
Aug 17, 2020
Venture Round - Antios Therapeutics
-4.4M
Apr 12, 2021
Series B - Antios Therapeutics
14-96.0M
Nov 03, 2021
Series B - Antios Therapeutics
20-75.0M

Recent Activity

There is no recent news or activity for this profile.